Postpartum Depression News & Updates
Caplyta: A New Add-On Option for Adults With Depression
- We May Soon Have a Blood Test to Predict Postpartum Depression
April 18, 2025 — The innovative advance could shift treatment from response to prevention, and redefine how we think about this common maternal condition.
- Depression Amid Pregnancy Linked to Years of Suicide Risk
January 11, 2024 — A pair of new studies of women living in Sweden suggests that any woman who has depression during or after pregnancy has a higher and longer risk of suicide, regardless of psychiatric history.
- Sky-High Cost of Postpartum Depression Drug Raises Concerns
November 8, 2023 — The price of a breakthrough postpartum treatment will be $15,900, pharmaceutical company Sage Therapeutics told investors Tuesday.
- First Pill for Postpartum Depression: What It Means for You
August 10, 2023 — WebMD asked several experts in mental health and women’s health to share their take on this new treatment option. What could it mean for easing symptoms like hopelessness, crankiness, and lack of interest in bonding with the baby – and, in some cases, thoughts of death or suicide?
- FDA Approves First Pill for Postpartum Depression
August 7, 2023 — The other approved therapy for postpartum depression is an IV drug. But the product requires long infusions in hospital settings and costs $34,000.
- Fast-Acting Postpartum Depression Drug is Effective
July 28, 2023 — The FDA is considering approving a postpartum depression medication, zuranolone, that can start working rapidly -- in as little as three days.
